One year after analyzing FDA’s AI medical device approvals, a new dataset confirms: growth continues, but acceleration is absent. While more young companies are joining the field, older firms like GE still dominate approvals—classic sustaining innovation. And Big Tech? Still barely on the board.

Smartphone apps that can diagnose pneumonia? FDA-approved machines that can diagnose conditions without a doctor? Robot psychotherapy? It’s not coming, it’s here now.